[go: up one dir, main page]

AU2002254116A1 - Compounds and pharmaceutical compositions for inhibiting mrp1 - Google Patents

Compounds and pharmaceutical compositions for inhibiting mrp1

Info

Publication number
AU2002254116A1
AU2002254116A1 AU2002254116A AU2002254116A AU2002254116A1 AU 2002254116 A1 AU2002254116 A1 AU 2002254116A1 AU 2002254116 A AU2002254116 A AU 2002254116A AU 2002254116 A AU2002254116 A AU 2002254116A AU 2002254116 A1 AU2002254116 A1 AU 2002254116A1
Authority
AU
Australia
Prior art keywords
compounds
pharmaceutical compositions
inhibiting mrp1
mrp1
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002254116A
Inventor
Jeffrey Daniel Cohen
Louis Nickolaus Jungheim
Brian Stephen Muehl
Kenneth Jeff Thrasher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2002254116A1 publication Critical patent/AU2002254116A1/en
Abandoned legal-status Critical Current

Links

AU2002254116A 2001-04-09 2002-03-27 Compounds and pharmaceutical compositions for inhibiting mrp1 Abandoned AU2002254116A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/282,642 2001-04-09

Publications (1)

Publication Number Publication Date
AU2002254116A1 true AU2002254116A1 (en) 2002-10-21

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002352950A1 (en) Compounds derived from an amine nucleus and pharmaceutical compositions comprising same
AU2002363361A1 (en) Pharmaceutical compositions containing oxybutynin
EP1450824A4 (en) Pharmaceutical composition
HUP0400974A3 (en) Peptide-based compounds and pharmaceutical compositions containing them
HUP0401333A3 (en) Spiropyrazole compounds and pharmaceutical compositions containing them
HK1072200A1 (en) Pro-micelle pharmaceutical compositions
GB0111597D0 (en) Pharmaceutical compositions
AU2002302147A1 (en) Pharmaceutical composition
GB0129117D0 (en) Pharmaceutical composition
GB0104752D0 (en) Pharmaceutical compositions
PL370037A1 (en) Pharmaceutical composition
AU2002246659A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
HK1068277A1 (en) Pharmaceutical compositions comprising chelidonineor derivatives thereof
AU2002246658A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
GB2382302B (en) Pharmaceutical compositions
AU2002254116A1 (en) Compounds and pharmaceutical compositions for inhibiting mrp1
AUPR529701A0 (en) Pharmaceutical composition
IL157411A0 (en) Pharmaceutical composition
AUPS317302A0 (en) Metastable pharmaceutical compositions
GB0126732D0 (en) Pharmaceutical compositions
AU2002100921A4 (en) Pharmaceutical composition
GB0125061D0 (en) Pharmaceutical composition
AU2002326822A1 (en) Pro-micelle pharmaceutical compositions
AU2002308066A1 (en) Pharmaceutical composition containing bulbophyllum
AU2002258464A1 (en) Compounds and methods for inhibiting mrp1